Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-29 22:49:38 - browse：625

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Pharma’s losing bet in New Jersey

knowledge

WSS

Beyond aggravation: Constipation is an American epidemic

The world needs the new pandemic treaty

Roche’s Alnylam deal shows drug firms interested in heart drugs

The Bio Revolution is changing business and society

U.S. death rates show how politics are affecting public health

Congress: Prevent baby formula shortages by passing a new bill

hotspot

Wikipedia

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Roche’s Alnylam deal shows drug firms interested in heart drugs

Medicare proposal to cover medical devices draws a mixed reaction

Unmasking the 'centricity' illusion in clinical trials

Medical leaders decry Supreme Court decision on affirmative action

Why we need mandatory labeling of GMO products

Drug repurposing or repositioning? The language matters

Bird flu makes raw milk dangerous to consume, mouse study finds

In Memoriam: Notable people who died in 2023

Will the FTC rein in IQVIA's health data empire?

Wikipedia

Senate panel puts off hardest PBM reforms for another day

Why we need mandatory labeling of GMO products

U.S. death rates show how politics are affecting public health

In the gardens at Boston Children's Hospital, families find sanctuary

Device maker Teleflex to acquire urology company for $600M

New Alzheimer's drugs heat up race for early detection blood tests

knowledge

hotspot

focus

focus